|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Intra-Cellular Therapies Inc. (ITCI)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-01-04 Sale |
2019-01-08 9:28 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO, Chairman |
52,202 | $11.58 | $604,310 | 1,190,909 (Direct) |
View |
| 2019-01-04 Sale |
2019-01-08 9:24 pm |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP |
24,566 | $11.58 | $284,418 | 80,951 (Direct) |
View |
| 2019-01-04 Sale |
2019-01-08 9:21 pm |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO |
24,566 | $11.58 | $284,383 | 80,951 (Direct) |
View |
| 2019-01-04 Sale |
2019-01-08 9:19 pm |
Intra-Cellular Therapies Inc. | ITCI | Vanover Kimberly E. VP |
10,156 | $11.52 | $116,979 | 80,951 (Direct) |
View |
| 2019-01-04 Sale |
2019-01-08 9:16 pm |
Intra-Cellular Therapies Inc. | ITCI | Davis Robert E SVP, Chief Scientific Officer |
9,564 | $11.46 | $109,630 | 75,554 (Direct) |
View |
| 2018-12-31 Sale |
2019-01-03 9:02 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO, Chairman |
17,478 | $11.09 | $193,831 | 1,184,305 (Direct) |
View |
| 2018-12-31 Sale |
2019-01-03 8:58 pm |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP |
7,807 | $11.09 | $86,580 | 32,320 (Direct) |
View |
| 2018-12-31 Sale |
2019-01-03 8:46 pm |
Intra-Cellular Therapies Inc. | ITCI | Vanover Kimberly E. VP |
4,834 | $11.1 | $53,657 | 35,670 (Direct) |
View |
| 2018-12-31 Sale |
2019-01-03 8:42 pm |
Intra-Cellular Therapies Inc. | ITCI | Davis Robert E SVP, Chief Scientific Officer |
4,834 | $11.11 | $53,706 | 53,553 (Direct) |
View |
| 2018-12-31 Sale |
2019-01-03 8:23 pm |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO |
7,807 | $11.09 | $86,580 | 38,490 (Direct) |
View |
| 2018-12-04 Sale |
2018-12-07 4:44 pm |
Intra-Cellular Therapies Inc. | ITCI | Davis Robert E SVP, Chief Scientific Officer |
899 | $13.53 | $12,163 | 31,155 (Direct) |
View |
| 2018-11-09 Sale |
2018-11-13 5:34 pm |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
32,000 | $18.17 | $581,580 | 1,143,731 (Direct Indirect) |
View |
| 2018-02-15 Sale |
2018-02-20 4:38 pm |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO |
49,700 | $20.02 | $995,165 | 33,351 (Direct) |
View |
| 2018-01-22 Sale |
2018-01-24 7:11 pm |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP |
25,500 | $18.03 | $459,765 | 191 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-01-08 Option Award |
2019-01-10 4:28 pm |
N/A 2029-01-07 |
Intra-Cellular Therapies Inc. | ITCI | Satlin Andrew EVP and Chief Medical Officer |
94,443 | $12.73 | 94,443 (Direct) |
View |
| 2019-01-08 Option Award |
2019-01-10 4:28 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Satlin Andrew EVP and Chief Medical Officer |
68,735 | $0 | 94,443 (Direct) |
View |
| 2019-01-08 Option Award |
2019-01-10 4:18 pm |
N/A 2029-01-07 |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
86,348 | $12.73 | 86,348 (Direct) |
View |
| 2019-01-08 Option Award |
2019-01-10 4:18 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
62,843 | $0 | 86,348 (Direct) |
View |
| 2019-01-04 Exercise |
2019-01-08 9:28 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO, Chairman |
6,604 | $0 | 1,190,909 (Direct) |
View |
| 2019-01-04 Exercise |
2019-01-08 9:28 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO, Chairman |
6,604 | $0 | 1,190,909 (Direct) |
View |
| 2019-01-04 Option Award |
2019-01-08 9:28 pm |
N/A 2029-01-07 |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO, Chairman |
172,697 | $12.73 | 1,190,909 (Direct) |
View |
| 2019-01-04 Option Award |
2019-01-08 9:28 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO, Chairman |
125,687 | $0 | 1,190,909 (Direct) |
View |
| 2019-01-04 Exercise |
2019-01-08 9:24 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP |
3,108 | $0 | 80,951 (Direct) |
View |
| 2019-01-04 Exercise |
2019-01-08 9:24 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP |
3,108 | $0 | 80,951 (Direct) |
View |
| 2019-01-04 Option Award |
2019-01-08 9:24 pm |
N/A 2029-01-07 |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP |
80,951 | $12.73 | 80,951 (Direct) |
View |
| 2019-01-04 Option Award |
2019-01-08 9:24 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP |
58,915 | $0 | 80,951 (Direct) |
View |
| 2019-01-04 Exercise |
2019-01-08 9:21 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO |
3,108 | $0 | 80,951 (Direct) |
View |
| 2019-01-04 Gift |
2019-01-08 9:21 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO |
1,200 | $0 | 80,951 (Direct) |
View |
| 2019-01-04 Exercise |
2019-01-08 9:21 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO |
3,108 | $0 | 80,951 (Direct) |
View |
| 2019-01-04 Option Award |
2019-01-08 9:21 pm |
N/A 2029-01-07 |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO |
80,951 | $12.73 | 80,951 (Direct) |
View |
| 2019-01-04 Option Award |
2019-01-08 9:21 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO |
58,915 | $0 | 80,951 (Direct) |
View |
| 2019-01-04 Exercise |
2019-01-08 9:19 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Vanover Kimberly E. VP |
1,554 | $0 | 80,951 (Direct) |
View |
| 2019-01-04 Exercise |
2019-01-08 9:19 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Vanover Kimberly E. VP |
1,554 | $0 | 80,951 (Direct) |
View |
| 2019-01-04 Option Award |
2019-01-08 9:19 pm |
N/A 2029-01-07 |
Intra-Cellular Therapies Inc. | ITCI | Vanover Kimberly E. VP |
80,951 | $12.73 | 80,951 (Direct) |
View |
| 2019-01-04 Option Award |
2019-01-08 9:19 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Vanover Kimberly E. VP |
58,915 | $0 | 80,951 (Direct) |
View |
| 2019-01-04 Option Award |
2019-01-08 9:16 pm |
N/A 2029-01-07 |
Intra-Cellular Therapies Inc. | ITCI | Davis Robert E SVP, Chief Scientific Officer |
75,554 | $12.73 | 75,554 (Direct) |
View |
| 2019-01-04 Option Award |
2019-01-08 9:16 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Davis Robert E SVP, Chief Scientific Officer |
54,988 | $0 | 75,554 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 9:02 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO, Chairman |
17,478 | $0 | 1,184,305 (Direct) |
View |
| 2018-12-31 Exercise |
2019-01-03 9:02 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO, Chairman |
11,258 | $0 | 1,184,305 (Direct) |
View |
| 2018-12-31 Exercise |
2019-01-03 9:02 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO, Chairman |
34,340 | $0 | 1,184,305 (Direct) |
View |
| 2018-12-31 Exercise |
2019-01-03 9:02 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO, Chairman |
11,258 | $0 | 1,184,305 (Direct) |
View |
| 2018-12-31 Exercise |
2019-01-03 9:02 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO, Chairman |
34,340 | $0 | 1,184,305 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 8:58 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP |
7,807 | $0 | 32,320 (Direct) |
View |
| 2018-12-31 Exercise |
2019-01-03 8:58 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP |
5,298 | $0 | 32,320 (Direct) |
View |
| 2018-12-31 Exercise |
2019-01-03 8:58 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP |
16,160 | $0 | 32,320 (Direct) |
View |
| 2018-12-31 Exercise |
2019-01-03 8:58 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP |
5,298 | $0 | 32,320 (Direct) |
View |
| 2018-12-31 Exercise |
2019-01-03 8:58 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP |
16,160 | $0 | 32,320 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 8:46 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Vanover Kimberly E. VP |
9,322 | $0 | 35,670 (Direct) |
View |
| 2018-12-31 Exercise |
2019-01-03 8:46 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Vanover Kimberly E. VP |
2,649 | $0 | 35,670 (Direct) |
View |
| 2018-12-31 Exercise |
2019-01-03 8:46 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Vanover Kimberly E. VP |
16,160 | $0 | 35,670 (Direct) |
View |
| 2018-12-31 Exercise |
2019-01-03 8:46 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Vanover Kimberly E. VP |
2,649 | $0 | 35,670 (Direct) |
View |
| 2018-12-31 Exercise |
2019-01-03 8:46 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Vanover Kimberly E. VP |
16,160 | $0 | 35,670 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 8:42 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Davis Robert E SVP, Chief Scientific Officer |
9,322 | $0 | 53,553 (Direct) |
View |
| 2018-12-31 Exercise |
2019-01-03 8:42 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Davis Robert E SVP, Chief Scientific Officer |
2,649 | $0 | 53,553 (Direct) |
View |
| 2018-12-31 Exercise |
2019-01-03 8:42 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Davis Robert E SVP, Chief Scientific Officer |
16,160 | $0 | 53,553 (Direct) |
View |
| 2018-12-31 Exercise |
2019-01-03 8:42 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Davis Robert E SVP, Chief Scientific Officer |
2,649 | $0 | 53,553 (Direct) |
View |
| 2018-12-31 Exercise |
2019-01-03 8:42 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Davis Robert E SVP, Chief Scientific Officer |
16,160 | $0 | 53,553 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 8:23 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO |
7,807 | $0 | 38,490 (Direct) |
View |
| 2018-12-31 Exercise |
2019-01-03 8:23 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO |
5,298 | $0 | 38,490 (Direct) |
View |
| 2018-12-31 Exercise |
2019-01-03 8:23 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO |
16,160 | $0 | 38,490 (Direct) |
View |
| 2018-12-31 Exercise |
2019-01-03 8:23 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO |
5,298 | $0 | 38,490 (Direct) |
View |
| 2018-12-31 Exercise |
2019-01-03 8:23 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO |
16,160 | $0 | 38,490 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 8:19 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
512 | $11.39 | 4,955 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 8:15 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
1,273 | $11.39 | 226,670 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 8:11 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | LERNER RICHARD A Director |
1,207 | $11.39 | 66,911 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 8:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Alafi Christopher D Director |
1,273 | $11.39 | 3,953,270 (Direct) |
View |
| 2018-12-10 Exercise |
2018-12-11 5:55 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO, Chairman |
50,000 | $1.5 | 1,138,707 (Direct) |
View |
| 2018-12-10 Exercise |
2018-12-11 5:55 pm |
N/A 2018-12-18 |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO, Chairman |
50,000 | $1.5 | 1,138,707 (Direct) |
View |
| 2018-12-04 Exercise |
2018-12-07 4:44 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Davis Robert E SVP, Chief Scientific Officer |
1,758 | $0 | 31,155 (Direct) |
View |
| 2018-12-04 Exercise |
2018-12-07 4:44 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Davis Robert E SVP, Chief Scientific Officer |
1,758 | $0 | 31,155 (Direct) |
View |
| 2018-10-22 Exercise |
2018-10-24 4:33 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | LERNER RICHARD A Director |
12,500 | $1.5 | 66,911 (Indirect) |
View |
| 2018-10-22 Exercise |
2018-10-24 4:33 pm |
N/A 2018-12-18 |
Intra-Cellular Therapies Inc. | ITCI | LERNER RICHARD A Director |
12,500 | $1.5 | 66,911 (Indirect) |
View |
| 2018-10-15 Option Award |
2018-10-17 4:28 pm |
N/A 2028-10-14 |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
55,300 | $18.59 | 55,300 (Direct) |
View |
| 2018-10-15 Option Award |
2018-10-17 4:28 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
40,344 | $0 | 55,300 (Direct) |
View |
| 2018-09-30 Option Award |
2018-10-02 8:11 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | LERNER RICHARD A Director |
633 | $21.7 | 54,411 (Indirect) |
View |
| 2018-09-30 Option Award |
2018-10-02 8:08 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
668 | $21.7 | 226,670 (Direct) |
View |
| 2018-09-30 Option Award |
2018-10-02 8:06 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
268 | $21.7 | 4,443 (Direct) |
View |
| 2018-09-30 Option Award |
2018-10-02 8:01 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Alafi Christopher D Director |
668 | $21.7 | 3,953,270 (Direct) |
View |
| 2018-06-29 Option Award |
2018-07-03 4:27 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | LERNER RICHARD A Director |
778 | $17.67 | 53,778 (Indirect) |
View |
| 2018-06-29 Option Award |
2018-07-03 4:22 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
282 | $17.67 | 4,175 (Direct) |
View |
| 2018-06-29 Option Award |
2018-07-03 4:20 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
820 | $17.67 | 226,670 (Direct) |
View |
| 2018-06-29 Option Award |
2018-07-03 4:17 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Alafi Christopher D Director |
820 | $17.67 | 3,953,270 (Direct) |
View |
| 2018-06-18 Option Award |
2018-06-20 4:52 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
14,189 | $0 | 14,189 (Direct) |
View |
| 2018-06-18 Option Award |
2018-06-20 4:49 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
14,189 | $0 | 14,189 (Direct) |
View |
| 2018-06-18 Option Award |
2018-06-20 4:47 pm |
2019-06-18 2028-06-17 |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
20,000 | $20.39 | 20,000 (Direct) |
View |
| 2018-06-18 Option Award |
2018-06-20 4:45 pm |
2019-06-18 2028-06-17 |
Intra-Cellular Therapies Inc. | ITCI | LERNER RICHARD A Director |
20,000 | $20.39 | 20,000 (Direct) |
View |
| 2018-06-18 Option Award |
2018-06-20 4:40 pm |
2019-06-18 2028-06-17 |
Intra-Cellular Therapies Inc. | ITCI | Alafi Christopher D Director |
20,000 | $20.39 | 20,000 (Direct) |
View |
| 2018-03-30 Option Award |
2018-04-03 4:35 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Alafi Christopher D Director |
688 | $21.05 | 3,953,270 (Direct) |
View |
| 2018-03-30 Option Award |
2018-04-03 4:33 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | LERNER RICHARD A Director |
653 | $21.05 | 53,000 (Direct) |
View |
| 2018-03-30 Option Award |
2018-04-03 4:31 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
688 | $21.05 | 226,670 (Direct) |
View |
| 2018-03-30 Option Award |
2018-04-03 4:19 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
237 | $21.05 | 3,893 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Thu, 17 Jan 2019 03:07:49 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |